article thumbnail

CMS Rolls up its Sleeves on Price Negotiations, Sets Agenda for 2026 Negotiated Prices

The FDA Law Blog

The memorandum outlines CMS’s priorities and timeline for the Initial Price Applicability Year 2026. The topics focus on issues relevant in the first three years of the Negotiation Program—2026 to 2028. Method for applying the MFP across different dosage forms and strengths of a selected drug.

Dosage 59
article thumbnail

Januvia generic availability, cost, and dosage

The Checkup by Singlecare

No generic version of Januvia is available in the United States, but this could change in 2026 when the main patent expires. The first patent, covering the dihydrogen phosphate salt of sitagliptin, expires on November 24, 2026. Both medications contain the same active ingredient and have the same dosages.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biopharmaceutical bioseparation systems market to value $20bn

European Pharmaceutical Review

billion by 2026, achieving a compound annual growth rate (CAGR) of 13.2 percent CAGR between 2022 and 2026. According to recent market research , the global market for biopharmaceutical bioseparation systems, estimated to value $13 billion in 2022, is projected to grow to $19.6

article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.

article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

With predictions that the global market for anticounterfeiting packaging is set to reach almost $250 billion by 2026, growth in authentication and anti-tamper devices such as holograms appear to have a healthy future.” Blister packs can also benefit from anticounterfeiting holography.

Packaging 111
article thumbnail

AstraZeneca’s Challenge to Price Negotiation Fails in Federal District Court

The FDA Law Blog

AstraZeneca also claimed that CMS’s revised guidance on the Negotiation Program for Price Applicability Year 2026 (“Guidance”) interpreted the IRA in two very faulty ways, which violated the Administrative Procedure Act (APA) and harmed and will continue to harm the company. The court found numerous flaws with this argument.

Dosage 64
article thumbnail

Ozempic for insulin resistance: What research shows

The Checkup by Singlecare

These findings have spurred further research, with ongoing clinical trials set to conclude in October 2026. Dosage and usage of Ozempic for insulin resistance Ozempic is an injectable prescription medicine that is meant to be used alongside diet and exercise for blood sugar control. mg weekly, depending on the condition being treated.

Dosage 98